Gastric acid secretion

Current Opinion in Gastroenterology

Volumn 32, Issue 6, 2016, Pages 452-460

  Schubert, Mitchell L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastrin; Histamine; HK ATPase; Parietal cell; Proton pump; Proton pump inhibitor; Somatostatin

Indexed keywords

ACETYLCHOLINE; CHLORIDE CHANNEL; GASTRIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; HISTAMINE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; HYDROGEN SULFIDE; MOTILIN; POTASSIUM CHANNEL; PROTON PUMP INHIBITOR; SOMATOSTATIN;

CALCIUM ABSORPTION; ENTEROCHROMAFFIN LIKE CELL; GASTRIN CELL; HUMAN; INTESTINE FLORA; INTRACELLULAR SIGNALING; IRON ABSORPTION; NEUROENDOCRINE SYSTEM; NONHUMAN; REVIEW; SOMATOSTATIN CELL; STOMACH ACID SECRETION; STOMACH PARIETAL CELL; DRUG EFFECTS; PHYSIOLOGY; SECRETION (PROCESS); STOMACH ACID; STOMACH MUCOSA;

CHLORIDE CHANNELS; GASTRIC ACID; GASTRIC MUCOSA; GASTRINS; GASTROINTESTINAL MICROBIOME; HISTAMINE; HUMANS; NEUROSECRETORY SYSTEMS; POTASSIUM CHANNELS; PROTON PUMP INHIBITORS; SOMATOSTATIN;

EID: 84986183504     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000308     Document Type: Review

References (43)

1. Hunt RH, Camilleri M, Crowe SE, et al. The stomach in health and disease. Gut 2015; 10:1650-1668.
2. Waldum HL, Kleveland PM, Fossmark R. Upper gastrointestinal physiology and diseases. Scand J Gastroenterol 2015; 50:649-656.
3. Betesh AL, Santa Ana CA, Cole JA, Fordtran JS. Is achlorhydria a cause of iron deficiency anemia? Am J Clin Nutr 2015; 102:9-19.
4. van Aerts RMM, van Deursen CTBM, Koek GH. Proton pump inhibitors reduce the frequency of phlebotomy in patients with hereditary hemochromatosis. Clin Gastroenterol Hepatol 2016; 14:147-152.
5. Haffner-Luntzer M, Heilmann A, Heidler V, et al. Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases posttraumatic bone loss in the intact skeleton. JOrthop Res 2016. [Epub ahead of print]
6. Levenstein D, Rosenstock S, Kart R, et al. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin Gastro Hepatol 2015; 13:498-506.
7. Marshall KM, Laval M, Sims I, et al. Retro-inverso forms of gastrin5-12 are as biologicallly active as glycine-extended gastrin in vitro but not in vivo. Peptides 2015; 74:16-22.
8. Tripathi S, Flobak A, Chawla K, et al. The gastrin and cholecystokinin receptors mediated signaling network: a scaffold for data analysis and new hypotheses on regulatory mechanisms. BMC Syst Biol 2015; 9:40.
9. Rettenberger AT, Schulze W, Breer H, Haid D. Analysis of the protein related receptor GPR92 in G-cells. Front Physiol 2015; 6:261.
10. Grong E, Graeslie H, Munkvold B, et al. Gastrin secretion after bariatric surgery-response to a protein-rich mixed meal following roux-en-Y gastric bypass and sleeve gastrectomy: a pilot study in normoglycemic woman. Obes Surg 2016; 7:1448-1456.
11. Lundell L, Vieth M, Gibson F, et al. Systematic review: the effect of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther 2015; 42:649-663.
12. Laval M, Baldwin GS, Shulkes A, Marshall KM. Increased gastrin gene expression provides a physiological advanatage to mice under hypoxic conditions. Am J Physiol Gastrointest Liver Physiol 2015; 308:G76-G84.
13. Rosentraeger MJ, Garbrecht N, Anlauf M, et al. Syndromic versus nonsyndromic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior. Virchows Arch 2016; 468:277-287.
14. Kasajima A, Fujishima F, Morikawa T, et al. G-cell hyperplasia of the stomach induces ECL-cell proliferation in the pyloric glands in a paracrinal manner. Pathol Int 2015; 65:259-263.
15. Panula P, Chazot PL, Cowart M, et al. International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 2015; 67:601-655.
16. Vuyyuru L, Schubert ML. Histamine, acting via H3 receptors, inhibits somatostatin and stimulates acid secretion in isolated mouse stomach. Gastroenterology 1997; 113:1545-1552.
17. Engelstoft MS, Lund ML, Grunddal KV, et al. Research resource: a chromogranin A reporter for serotonin and histamine secreting enteroendocrine cells. Mol Endocrinol 2015; 29:1658-1671.
18. Laermans J, Vancleef L, Tack J, Depoortere I. Role of the clock gene Bmal1 and the gastric ghrelin-secreting cell in the circadian regulation of the ghrelin-GOAT system. Sci Rep 2015; 5:16748.
19. Goswami C, Shimada Y, Yoshimura M, et al. Motilin stimulates gastric acid secretion in coordination with ghrelin in Suncus murinus. PloS ONE 2015; 10:e0131554.
20. Sun H, Zhang J, Shi Y, et al. Effect of exogenous hydrogen sulfide on gastric acid secretion. J Gastroenterol Hepatol 2016; 31:1280-1283.
21. Egerod KL, Engelstoft MS, Lund ML, et al. Transcriptional and functional characterization of the G protein-coupled receptor repertoire of gastric somatostatin cells. Endocrinology 2015; 156:3909-3923.
22. Adriaenssens A, Lam BYH, Billing L, et al. A transcriptome-led exploration of molecular mechanisms regulating somatostatin-producing D-cells in the gastric epithelium. Endocrinology 2015; 156:3924-3936.
23. Smits MM, Tonneijck L, Muskiet MHA, et al. Gastrointestinal actions of GLP-1 based therapies: glycaemic control beyond the pancreas. Diabetes Obes Metab 2016; 18:224-235.
24. Abdul-Hussein M, Freeman J, Castell D. Concomitant administration of a histamine2 receptor antagonist and proton pump inhibitor enhances gastric acid suppression. Pharmacotherapy 2015; 35:1124-1129.
25. Fujii T, Takahashi Y, Takeshima H, et al. Inhibition of gastric H+,K+-ATPase by 4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), an inhibitor of volume-regulated anion channel. Eur J Pharmacol 2015; 765:34-41.
26. Hwang IY, Jeong CS. Gastroprotective activities of sennoside A and sennoside B via the up-regulation of prostaglandin E2 and the inhibition of H+/K+-ATPase. Biomol Ther 2015; 23:458-464.
27. Hammond CE, Beeson C, Suarez G, et al. Helicobacter pylori virulence factors affecting gastric proton pump expression and acid secretion. Am J Physiol Gastrointest Liver Physiol 2015; 309:G193-G201.
28. Jiang H, Wang W, Zhang Y, et al. Cell polarity kinase MST4 cooperates with cAMP-dependent kinase to orchestrate histamine-stimulated acid secretion in gastric parietal cells. J Biol Chem 2015; 47:28272-28285.
29. Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016; 176:238-246.
30. Gomm W, von Holt K, Thome F, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 2016; 73:410-416.
31. Shah NH, LePendu P, Bauer-Mehren A, et al. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLOS ONE 2015; 10:e0124653.
32. Khan MA, Kamal S, Khan S, et al. Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol 2015; 27:1327-1336.
33. Wang YP, Liu CJ, Chen TJ, et al. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study. Aliment Pharmacol Ther 2015; 41:1775-1781.
34. Attwood SE, Ell C, Galmiche JP, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther 2015; 41:1162-1174.
35. Tsuda A, Suda W, Morita H, et al. Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract. Clin Transl Gastroenterol 2015; 6:E89.
36. Freeberg DE, Toussaint NC, Chen SP, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology 2015; 149:883-885.
37. Melgar S, Nieuwdorp M. Are proton pump inhibitors affecting intestinal microbiota health. Gastroenterology 2015; 149:848-850.
38. Jackson MA, Goodrich JK, Maxan ME, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 2015; 65:749-756.
39. Scott DR, Munson KB, Marcus EA, et al. The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase. Aliment Pharmacol Ther 2015; 42:1315-1326.
40. Sakurai Y, Mori Y, Okamoto H, et al. Randomised clinical trial: acid-inhibitory effect of vonoprazan 20 mg compared with esomeprazole 20mg or rabeprazole 10mg in healthy adult male subjects-a randomized open-label crossover study. Aliment Pharmacol Ther 2016; 43:240-251.
41. Ashida K, Sakurai Y, Nishimura A, et al. Randomised clinical trial: a doseranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther 2015; 42:685-695.
42. Yuan J, Liu W, Karvar S, et al. Potassium channel KCNJ15 is required for histamine-stimulated gastric acid secretion. Am J Physiol Cell Physiol 2015; 309:C264-C270.
43. Nighot MP, Nighot PK, Ma TY, et al. Genetic ablation of the ClC-1 Cl-channel disrupts mouse gastric parietal cell acid secretion. PLos One 2015; 10:e0138174.